Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004974177 | SCV005557881 | uncertain significance | Inborn genetic diseases | 2024-11-07 | criteria provided, single submitter | clinical testing | The c.1202C>T (p.S401L) alteration is located in exon 3 (coding exon 3) of the COG8 gene. This alteration results from a C to T substitution at nucleotide position 1202, causing the serine (S) at amino acid position 401 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005017330 | SCV005644366 | uncertain significance | COG8-congenital disorder of glycosylation | 2024-02-20 | criteria provided, single submitter | clinical testing |